From the 10/13/17 news release:

"The Company has applied to TSX for an exemption from the requirement to obtain shareholder approval for the private placement based on the financial hardship exemption......"

"As a consequence of relying upon the financial hardship exemption under Section 604(e) of the TSX Company Manual, the Company expects that the TSX will commence a remedial delisting review, which is normal practice when a listed issuer seeks to rely on this exemption."

Based on today's announcement of the closing of the Hepalink Private Placement w/o shareholder approval, I'm assuming that the application to TSX for financial hardship exemption was approved. Now just the formality of the de-listing review?

BearDownAZ